Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 490.00K | £ 714.00K | £ 402.00K | £ 752.00K | £ 3.04M |
Total Assets | £ 36.23M | £ 32.20M | £ 40.41M | £ 40.71M | £ 40.95M |
Total Debt | £ 14.25M | £ 10.60M | £ 9.62M | £ 9.88M | £ 10.05M |
Net Debt | £ 13.76M | £ 9.88M | £ 9.22M | £ 9.13M | £ 7.01M |
Total Liabilities | £ 24.27M | £ 19.98M | £ 19.39M | £ 19.46M | £ 19.66M |
Stockholders Equity | £ 11.95M | £ 12.23M | £ 20.65M | £ 20.89M | £ 19.84M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |